Trial Details
RECRUITINGBasic Information
| Clinical ID | c207 |
|---|---|
| Identifier | NCT06962020 |
| Trial Title | Selection and Efficacy-Influencing Factors of First-Line Biologic Agents in Moderate-to-Severe Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis (UC) |
| Interventions | DRUG: first-line biologic：IFX|DRUG: first-line biologic:VDZ |
Participant Information
| Sponsor | Xijing Hospital of Digestive Diseases |
|---|---|
| City | Xi'an |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2025-04-30 |
|---|---|
| Primary Completion Date | 2025-11-20 |
| Completion Date | 2025-11-20 |